• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Document › Details

Biognosys AG. (8/4/11). "Press Release: Meet Biognosys at HUPO / Geneva. Biognosys AG Is Participating in the 10th Annual World Congress of the Human Proteome Organisation in Geneva".

	Region	Genève (Geneva) GE
	Country	Switzerland
	Organisation	Biognosys AG
	Organisation 2	HUPO (Human Proteome Organisation)
	Product	multiple reaction monitoring (MRM) technology
	Product 2	HUPO 2011 10th Annual World Congress, Geneva
	Person	Malmström, Johan (Biognosys 200809– CSO + co-founder)

Biognosys AG is attending HUPO 10th Annual World Congress in Geneva, Switzerland, which is being held on September, 3rd - 7th, 2011.

Biognosys CSO, Prof. Johan Malmström is holding a presentation "Proteome-wide SRM analysis of complete microbial proteomes - a case study in Streptococcus pyogenes virulence mechanisms". In his talk Prof. Malmström will discuss the SRM / MRM approach co-developed by Biognosys that has been successfully applied to target complete microbial proteomes. In this study, bacterial proteins were quantified in follow-up experiments demonstrating the capability of SRM / MRM to outline the spatial proteome. This approach enables identification of key regulatory mechanisms of bacterial virulence resulting in the rapid discovery of proteins relevant for therapeutic intervention.

Reto Ossola, Head of Biomarker Research at Biognosys, is presenting the results of the internal study focusing on discovery and validation of biomarker for recurring breast cancer in human tissue. This study shows advantages of the integrated workflow for biomarker discovery using semi-quantitative shotgun proteomics for candidates' pre-selection and targeted proteomics based on LC-MRM for candidates' validation.

HUPO 2011 participants are welcome to visit Biognosys booth #1151 to find out more about advances in targeted proteomics and scheduled MRM as well as about Biognosys research tools and services. Please contact us at drugdevelopment@biognosys.ch if you wish to schedule an appointment with one of our specialists.

Record changed: 2011-11-25

More documents for Biognosys AG

• [1] [iito] Business Intelligence. (3/13/12). "[MSC] Newsletter February 2012". Bremen....
• [2] Biognosys AG. (2/16/12). "Press Release: Skyline, the Most Popular Software for Targeted Proteomics Integrates Now iRT"....
• [3] Biognosys AG. (1/3/12). "Press Release: Biognosys and ETH Zurich Receive CHF 1.5m Funding from CTI"....
• [4] Biognosys AG. (12/7/11). "Press Release: Biognosys Collaborates with M2 to Develop Commercial MRM Software"....
• [5] Biognosys AG. (10/31/11). "Press Release: Biognosys Raises CHF 2.7m in Series A Financing. Biognosys Attracted Venture Capital from Experienced Investors including Syngenta Ventures"....
• [6] Biognosys AG. (9/16/11). "Press Release: iRT Concept Is Gaining Acceptance. Biognosys Is Invited to Present Its iRT Concept for Mass Spectrometry Specialists"....
• [7] Biognosys AG. (9/9/11). "Press Release: Biognosys Celebrates 3rd Anniversary. On September 9th, 2011, Biognosys Turns 3 Years Old..."....
• [8] Biognosys AG. (7/4/11). "Press Release: Deal with Novartis Vaccines and Diagnostics. Siena, Italy – Biognosys Is Entering into a Collaboration with Novartis Vaccines and Diagnostics"....
• [9] Biognosys AG. (5/24/11). "Press Release: MRMbase.com. The World’s Most Validated Library of Mass Spec Assays"....
• [10] Biognosys AG. (5/24/11). "Press Release: Biognosys at ASMS / Denver"....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.